<DOC>
	<DOCNO>NCT02593149</DOCNO>
	<brief_summary>To assess blood stream infection participant use two FDA-cleared device : ClearGuard HD end cap compare Tego® connector Curos® Tego disinfect port protector .</brief_summary>
	<brief_title>Product Evaluation Effectiveness ClearGuard® HD End Cap</brief_title>
	<detailed_description>Prospective , cluster-randomized , open-label , post market , comparative effectiveness evaluation facility participate 12 month .</detailed_description>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>All patient dialyze central venous catheter Known allergy chlorhexidine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>